Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Community Pharmacy Wales and Welsh government ink pact on Community Pharmacy Contractual Framework

Community Pharmacy Wales and the Welsh government have entered an agreement on Thursday (December 16), enabling all pharmacies to deliver provision of contraception, treatment for common minor ailments, and access to repeat medicines in an emergency.

Expansion of clinical community pharmacy service will be supported with an increased funding of £20 million a year by April 2024 from the current level of £11.4m.


The two bodies have been negotiating the terms of agreement, which also includes plans to roll out a Wales-wide pharmacy prescribing service, allowing trained pharmacists to treat an extended range of conditions that currently require GP visits.

The agreement will allow patients to access NHS services closer to home which in turn would free up GP and other NHS services for patients with more complex needs.

Eluned Morgan MS, minister for Health and Social Services said: “I welcome the positive approach to negotiations taken by Community Pharmacy Wales, embracing our ambition for a reimagined community pharmacy service, which is an integral part of a strong primary care landscape.”

“The new arrangements recognise and reward pharmacies, which understand, share and deliver our longer-term ambition to provide effective, high-quality, sustainable healthcare.”

Lauding the agreement, Mark Lyonette, National Pharmacy Association (NPA) chief executive said, it shows “the Welsh government’s willingness to back its ambitions for pharmacy service development with financial investment.

“NPA members across Wales provide invaluable access to care, professional support, and are highly trusted.  Collaborative leadership in Wales has been a spur to many positive outcomes that benefit patients and we look forward to working with our members to make sure they continue to deliver great care to the people of Wales.”

More For You

B&S Group has mourned the death of Ketan Shah in the Air India plane crash in India last week

B&S Group has mourned the death of Ketan Shah in the Air India plane crash in India last week

LinkedIn

B&S Group mourns the death of Ketan Shah in Air India crash

Pharmaceutical Supplier B&S Group has mourned the death of Ketan Shah in the Air India plane crash in India last week.

A post on the company's LinkedIn page stated, "Ketan was not just a valued part of the B&S Group family; he was a bright light in every room, known for his warmth, integrity, and unwavering positivity. His legacy remains in the friendships he nurtured and the lives he touched."

Keep ReadingShow less
NHS app to boost clinical trials

The focus is on encouraging people from underrepresented groups, including minorities from African and Asian heritage, to sign up for clinical trials.

iStock

Government to use NHS app to boost clinical trials

The government’s 10-Year Health Plan is expected to provide a fillip to clinical trials, and it plans to make use of the NHS App to encourage people to sign up as participants.

People will be able to sign up for the NIHR Be Part of Research service (bepartofresearch.uk) on the NHS App for the trials best suited to their interests and needs.

Keep ReadingShow less
US pharma bets big on China to snap up potential blockbuster drugs

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies

US pharma bets big on China to snap up potential blockbuster drugs

US drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies. That compares with just two such deals in the year-earlier period, according to data from GlobalData provided exclusively to Reuters.

Keep ReadingShow less
Alliance Healthcare team raises thousands with charity bike ride to Paris

The Alliance Healthcare team

Alliance Healthcare team raises thousands with charity bike ride to Paris

Eight Alliance Healthcare team members raised over £55,000 for Theodora Children’s Charity by cycling from Surrey to Paris.

From June 13th-15th, the team took on the gruelling 300 mile cross-border Tour D’Alliance 2025 challenge and raised vital funds to support children who may be living with serious health challenges through Theodora Children’s Charity’s Giggle Doctor programme.

Keep ReadingShow less
Over four million flu vaccines across England in the 2024/25 winter flu season.

Over four million flu vaccines across England in the 2024/25 winter flu season.

CCA release

Community pharmacy administered over four million flu vaccines

Community pharmacy administered over four million flu vaccines across England in the 2024/25 winter flu season, the highest outside of the pandemic, according to the Company Chemists’ Association.

This is nearly 10 per cent higher than the number of flu vaccines administered in 2023/24.

Keep ReadingShow less